Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
MLTX
MLTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest MLTX ETF News Today | Earnings, Events & Price Alerts
MLTX News
Significant Milestones in Biotech Sector This Week
4d ago
NASDAQ.COM
MoonLake Immunotherapeutics Receives Upgraded Rating
Feb 23 2026
Yahoo Finance
Vanda Pharmaceuticals Shares Surge 33% in Pre-Market Trading
Feb 23 2026
Benzinga
Trump Announces Global Tariff Increase to 15%
Feb 23 2026
stocktwits
MoonLake's S-OLARIS Trial Data Shows Positive Results
Feb 23 2026
stocktwits
MoonLake's S-OLARIS Trial Results Show Significant Efficacy for Sonelokimab
Feb 22 2026
Newsfilter
MoonLake Immunotherapeutics Receives FDA Fast Track Designation for Sonelokimab
Feb 19 2026
stocktwits
Investors Track Economic Data and Fed Minutes for Clarity
Feb 18 2026
stocktwits
Cormorant Increases MoonLake Stake Above 6%
Feb 18 2026
stocktwits
Merck Seeks Acquisitions to Strengthen Drug Portfolio
Feb 17 2026
stocktwits
Imagene Appoints New Chief Medical Officer to Drive Clinical Development
Feb 10 2026
Newsfilter
BioTech Surge: MoonLake Rises 30% Following FDA Success
Feb 03 2026
Marketbeat
Avalo Therapeutics Completes Enrollment for AVTX-009 Trial
Feb 02 2026
Benzinga
MoonLake Immunotherapeutics Receives FDA Fast Track Designation for Sonelokimab
Feb 02 2026
seekingalpha
FDA Grants Fast Track Designation to Sonelokimab for PPP Treatment
Feb 02 2026
Newsfilter
TSMC Raises 2026 Capex to $52B-$56B, Boosting Market Confidence
Jan 16 2026
NASDAQ.COM
Show More News
